PO09

Sergej Sergeich Romanenko
{"title":"PO09","authors":"Sergej Sergeich Romanenko","doi":"10.1016/j.brachy.2023.06.110","DOIUrl":null,"url":null,"abstract":"According to our experience, intracavitary brachytherapy of metastasis into vagina is not effective, especially in the case of volumetric tumor. As a rule we use intratissue brachytherapy with an intracavitary applicator of maximal diameter. Patient and Methods In 2020 Ca of transverse colon was diagnosed in a patient 58 years old, female. Ultrasonography, CT, MRI investigations and biopsy confirmed mts in both ovarian, pathological retroperitoneal, mesenteric and intracranial lymph nodes, left lobe of liver. First line of treatment included surgery, chemotherapy and hormone therapy. Operations: median laparotomy, right-sided hemicolectomy, atypical resection of the left lobe of liver. Chemotherapy (14 courses) - 8 courses with oxaliplatin and capecitabine and 6 courses with irinotecan. Mts into vagina were revealed a month after completing the treatment. 39,6 Gy (2.2 Gy*18 fractions) to pelvis with concomitant intracavitary brachytherapy 7Gy*4, total dose 28 Gy with normalization 5 mm from mucosa was delivered. In three months volumetric lesion in vagina right wall was confirmed at CT scans and visually. Intratissue brachytherapy with rigid needles was decided to use. Dose distribution and needle location is shown at the Figure. Needle insertion was done by freehand under anesthesia. Doses amounted to 30 Gy (1 time per week, 10 Gy fraction). Treatment was carried out at Microselectron 30 channels on the base of CT scans. Radiation reactions (burning and profuse discharge) lasted one month approximately. Results In 3 months CT with contrast did not show the presence of pathological foci in the body. And visually vagina had no signs of a tumor. Conclusion It was shown that intratissue brachytherapy is effective in the treatment of tumors affecting vagina. According to our experience, intracavitary brachytherapy of metastasis into vagina is not effective, especially in the case of volumetric tumor. As a rule we use intratissue brachytherapy with an intracavitary applicator of maximal diameter. In 2020 Ca of transverse colon was diagnosed in a patient 58 years old, female. Ultrasonography, CT, MRI investigations and biopsy confirmed mts in both ovarian, pathological retroperitoneal, mesenteric and intracranial lymph nodes, left lobe of liver. First line of treatment included surgery, chemotherapy and hormone therapy. Operations: median laparotomy, right-sided hemicolectomy, atypical resection of the left lobe of liver. Chemotherapy (14 courses) - 8 courses with oxaliplatin and capecitabine and 6 courses with irinotecan. Mts into vagina were revealed a month after completing the treatment. 39,6 Gy (2.2 Gy*18 fractions) to pelvis with concomitant intracavitary brachytherapy 7Gy*4, total dose 28 Gy with normalization 5 mm from mucosa was delivered. In three months volumetric lesion in vagina right wall was confirmed at CT scans and visually. Intratissue brachytherapy with rigid needles was decided to use. Dose distribution and needle location is shown at the Figure. Needle insertion was done by freehand under anesthesia. Doses amounted to 30 Gy (1 time per week, 10 Gy fraction). Treatment was carried out at Microselectron 30 channels on the base of CT scans. Radiation reactions (burning and profuse discharge) lasted one month approximately. In 3 months CT with contrast did not show the presence of pathological foci in the body. And visually vagina had no signs of a tumor. It was shown that intratissue brachytherapy is effective in the treatment of tumors affecting vagina.","PeriodicalId":93914,"journal":{"name":"Brachytherapy","volume":"184 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brachytherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.brachy.2023.06.110","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

According to our experience, intracavitary brachytherapy of metastasis into vagina is not effective, especially in the case of volumetric tumor. As a rule we use intratissue brachytherapy with an intracavitary applicator of maximal diameter. Patient and Methods In 2020 Ca of transverse colon was diagnosed in a patient 58 years old, female. Ultrasonography, CT, MRI investigations and biopsy confirmed mts in both ovarian, pathological retroperitoneal, mesenteric and intracranial lymph nodes, left lobe of liver. First line of treatment included surgery, chemotherapy and hormone therapy. Operations: median laparotomy, right-sided hemicolectomy, atypical resection of the left lobe of liver. Chemotherapy (14 courses) - 8 courses with oxaliplatin and capecitabine and 6 courses with irinotecan. Mts into vagina were revealed a month after completing the treatment. 39,6 Gy (2.2 Gy*18 fractions) to pelvis with concomitant intracavitary brachytherapy 7Gy*4, total dose 28 Gy with normalization 5 mm from mucosa was delivered. In three months volumetric lesion in vagina right wall was confirmed at CT scans and visually. Intratissue brachytherapy with rigid needles was decided to use. Dose distribution and needle location is shown at the Figure. Needle insertion was done by freehand under anesthesia. Doses amounted to 30 Gy (1 time per week, 10 Gy fraction). Treatment was carried out at Microselectron 30 channels on the base of CT scans. Radiation reactions (burning and profuse discharge) lasted one month approximately. Results In 3 months CT with contrast did not show the presence of pathological foci in the body. And visually vagina had no signs of a tumor. Conclusion It was shown that intratissue brachytherapy is effective in the treatment of tumors affecting vagina. According to our experience, intracavitary brachytherapy of metastasis into vagina is not effective, especially in the case of volumetric tumor. As a rule we use intratissue brachytherapy with an intracavitary applicator of maximal diameter. In 2020 Ca of transverse colon was diagnosed in a patient 58 years old, female. Ultrasonography, CT, MRI investigations and biopsy confirmed mts in both ovarian, pathological retroperitoneal, mesenteric and intracranial lymph nodes, left lobe of liver. First line of treatment included surgery, chemotherapy and hormone therapy. Operations: median laparotomy, right-sided hemicolectomy, atypical resection of the left lobe of liver. Chemotherapy (14 courses) - 8 courses with oxaliplatin and capecitabine and 6 courses with irinotecan. Mts into vagina were revealed a month after completing the treatment. 39,6 Gy (2.2 Gy*18 fractions) to pelvis with concomitant intracavitary brachytherapy 7Gy*4, total dose 28 Gy with normalization 5 mm from mucosa was delivered. In three months volumetric lesion in vagina right wall was confirmed at CT scans and visually. Intratissue brachytherapy with rigid needles was decided to use. Dose distribution and needle location is shown at the Figure. Needle insertion was done by freehand under anesthesia. Doses amounted to 30 Gy (1 time per week, 10 Gy fraction). Treatment was carried out at Microselectron 30 channels on the base of CT scans. Radiation reactions (burning and profuse discharge) lasted one month approximately. In 3 months CT with contrast did not show the presence of pathological foci in the body. And visually vagina had no signs of a tumor. It was shown that intratissue brachytherapy is effective in the treatment of tumors affecting vagina.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
PO09
根据我们的经验,腔内近距离治疗转移到阴道是无效的,特别是在体积肿瘤的情况下。作为一个规则,我们使用组织内近距离治疗与最大直径的腔内涂抹器。患者与方法2020年确诊横结肠Ca 1例,年龄58岁,女性。超声、CT、MRI检查及活检均证实卵巢、病理腹膜后、肠系膜及颅内淋巴结、肝左叶均有mts。一线治疗包括手术、化疗和激素治疗。手术:剖腹正中开腹,右侧半结肠切除术,非典型左肝叶切除术。化疗(14个疗程)-奥沙利铂加卡培他滨8个疗程,伊立替康6个疗程。在完成治疗一个月后,发现了阴道内的Mts。盆腔内近距离放射治疗7Gy*4,总剂量28 Gy,距粘膜5 mm处给予放疗。3个月后,经CT及目测证实阴道右壁体积病变。决定采用硬针组织内近距离治疗。剂量分布和针头位置如图所示。麻醉下徒手插针。剂量为30 Gy(每周1次,10 Gy分数)。在CT扫描的基础上进行微选择30通道治疗。辐射反应(燃烧和大量放电)持续约一个月。结果3个月CT造影未见体内病变灶。从视觉上看阴道也没有肿瘤的迹象。结论组织内近距离放疗是治疗阴道肿瘤的有效方法。根据我们的经验,腔内近距离治疗转移到阴道是无效的,特别是在体积肿瘤的情况下。作为一个规则,我们使用组织内近距离治疗与最大直径的腔内涂抹器。2020年确诊横结肠Ca 1例,年龄58岁,女性。超声、CT、MRI检查及活检均证实卵巢、病理腹膜后、肠系膜及颅内淋巴结、肝左叶均有mts。一线治疗包括手术、化疗和激素治疗。手术:剖腹正中开腹,右侧半结肠切除术,非典型左肝叶切除术。化疗(14个疗程)-奥沙利铂加卡培他滨8个疗程,伊立替康6个疗程。在完成治疗一个月后,发现了阴道内的Mts。盆腔内近距离放射治疗7Gy*4,总剂量28 Gy,距粘膜5 mm处给予放疗。3个月后,经CT及目测证实阴道右壁体积病变。决定采用硬针组织内近距离治疗。剂量分布和针头位置如图所示。麻醉下徒手插针。剂量为30 Gy(每周1次,10 Gy分数)。在CT扫描的基础上进行微选择30通道治疗。辐射反应(燃烧和大量放电)持续约一个月。3个月CT造影未见体内病变灶。从视觉上看阴道也没有肿瘤的迹象。研究表明,组织内近距离放射治疗对阴道肿瘤有较好的疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
How do you do it?: Gynecologic brachytherapy best practices at high volume institutions within the United States and Canada. Quality control study of cervical cancer interstitial brachytherapy treatment plans using statistical process control. 3D-printed radiopaque episcleral plaques with radioactive collimating cavities for enhanced dose delivery in brachytherapy. Ultrasound and CT-guided implantation of iodine-125 seeds combined with transarterial chemoembolization for recurrent hepatocellular carcinoma at complex sites after hepatectomy. HDR brachytherapy combined with external beam radiotherapy for unfavorable localized prostate cancer: A single center experience from inception to standard of care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1